Stephens reaffirmed their equal weight rating on shares of Anika Therapeutics (NASDAQ:ANIK – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $24.00 target price on the biotechnology company’s stock. Several other equities research analysts have also commented on ANIK. Barrington Research reaffirmed an outperform rating and […]
Appoints Joseph Capper and William Jellison to Board of DirectorsAnnounces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 Anika Therapeutics, Inc. , a global joint.
Global Topical Wound Agents Market Size To Exceed USD 3.7 globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.